Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
+12,600
New +$1.21M ﹤0.01% 2109
2026
Q1
Sell
-7,000
Closed -$706K 2959
2025
Q4
$706K Hold
7,000
﹤0.01% 2355
2025
Q3
$863K Sell
7,000
-300
-4% -$37.2K ﹤0.01% 2174
2025
Q2
$877K Sell
7,300
-1,500
-17% -$200K ﹤0.01% 2085
2025
Q1
$1.3M Buy
+8,800
New +$1.34M ﹤0.01% 1887
2024
Q4
Sell
-19,200
Closed -$3.13M 2808
2024
Q3
$3.13M Buy
+19,200
New +$2.85M 0.01% 1475
2023
Q1
Sell
-2,200
Closed -$309K 2710
2022
Q4
$309K Buy
+2,200
New +$312K ﹤0.01% 1981
2021
Q2
Sell
-50,000
Closed -$9.64M 2013
2021
Q1
$9.64M Buy
+50,000
New +$9.62M 0.05% 497
2020
Q2
Sell
-80,000
Closed -$13.9M 1165
2020
Q1
$13.9M Buy
+80,000
New +$13.2M 0.16% 176
2013
Q4
Sell
-200,000
Closed -$4.38M 509
2013
Q3
$4.38M Buy
+200,000
New +$16.9M 0.06% 367

Other funds holding CLX

Dmitry Balyasny's CLX Position: Q2 2026 in Review

Dmitry Balyasny increased its Clorox (CLX) stake by 151% in Q2 2026, buying an estimated $23.8M and bringing the position to 411,686 shares worth $39.3M. The position accounts for 0.05% of the portfolio, ranked #438.

Dmitry Balyasny first reported a position in CLX in Q4 2015 and has held it in 29 quarters since. The position peaked at $231M in Q4 2024. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Dmitry Balyasny held 411,686 shares of Clorox worth $39.3M as of Q2 2026.
  • Dmitry Balyasny bought 247,953 Clorox shares in Q2 2026, an estimated $23.8M.
  • Clorox made up 0.05% of Dmitry Balyasny's portfolio in Q2 2026, its #438 holding.
  • Dmitry Balyasny first reported a position in Clorox in Q4 2015 and has held it in 29 quarters since.
  • Dmitry Balyasny's Clorox position peaked at $231M in Q4 2024.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.